# Tandem Diabetes Care acquires infusion set developer Capillary Biomedical

Tandem Diabetes Care, Inc. announced its acquisition of Capillary Biomedical, an infusion set developer. Financial terms were not disclosed.

- Type: Acquisition
- Announced: 2022-07-21
- Where: United States
- Status: completed
- Products: infusion sets, insulin delivery systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Tandem Diabetes Care](https://endata.com/companies/29150.md) (acquirer)
- [Capillary Biomedical](https://endata.com/companies/64288.md) (target)

## Sources

- [investor.tandemdiabetes.com](https://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-diabetes-care-acquires-infusion-set-developer-capillary/), 2022-07-21: "Through this acquisition, and through our efforts with existing infusion set partners, we look forward to developing new and innovative infusion set solutions that are designed to extend wear time and enhance user experience, while reducing occlusions, body burden and waste."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.